-transparent.png){kind=logo}
The isolated isovolumic rat heart was used as a model of cardiac hypoxia. Force of cardiac contraction and cardiac cyclic nucleotide levels (cyclic GMP and cyclic AMP) were monitored in hearts subjected to hypoxia for 5 min and allowed to recover by reoxygenation. Hearts were obtained from both control animals and animals pretreated with methylprednisolone at 18 hr and 1 hr prior to sacrifice. Myocardial levels of cyclic GMP which were significantly (p less than 0.05) elevated above control during all periods of hypoxia were found to be lower when hearts were pretreated with methylprednisolone prior to hypoxic exposure. Hearts of animals pretreated with methylprednisolone also demonstrated better recovery during reoxygenation than did control hearts. These studies suggest that methylprednisolone may be beneficial in the prevention of myocardial failure following hypoxia via a modulation in myocardial cyclid GMP content.
R W Busuttil, and
R M Graeff, and
W J George
January 1977,
Doklady Akademii nauk SSSR,
R W Busuttil, and
R M Graeff, and
W J George
January 1976,
Recent advances in studies on cardiac structure and metabolism,
R W Busuttil, and
R M Graeff, and
W J George
February 1978,
Cardiovascular research,
R W Busuttil, and
R M Graeff, and
W J George
May 1976,
Cardiovascular research,
R W Busuttil, and
R M Graeff, and
W J George
August 1997,
Biochemical pharmacology,
R W Busuttil, and
R M Graeff, and
W J George
September 1982,
Cardiovascular research,
R W Busuttil, and
R M Graeff, and
W J George
December 1975,
The Journal of thoracic and cardiovascular surgery,
R W Busuttil, and
R M Graeff, and
W J George
May 2017,
Bulletin of experimental biology and medicine,
R W Busuttil, and
R M Graeff, and
W J George
January 1976,
Comparative biochemistry and physiology. C: Comparative pharmacology,
R W Busuttil, and
R M Graeff, and
W J George
January 1974,
Basic research in cardiology,
